Company:  NANOSPHERE INC (NSPH)
Form Type:  10-Q
Filing Date:  11/7/2012 
CIK:  0001105184 
Address:  4088 COMMERCIAL AVE 
City, State, Zip:  NORTHBROOK, Illinois 60062 
Telephone:  847-400-9000 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$1.82  
Change: 
-0.03 (-1.62%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$139.99M
Description of Business
References herein to �we,� �us,� �our� or �the Company� refer to Nanosphere, Inc. unless the context specifically requires otherwise. Overview We are dedicated to enhancing medicine by providing targeted molecular diagnostic tests that can lead to earlier disease detection, optimal patient treatment and improved healthcare economics. Our platform, the Verigene� System, enables clinicians to rapidly identify and treat the bacteria and viruses responsible for some of the most complex, costly and deadly infectious diseases. The Verigene System includes a bench-top molecular diagnostics workstation that is an advanced platform for genomic and protein testing. The Verigene System is differentiated by its ease of use, superior analytical performance and ability to detect many targets on a single test, referred to as �multiplexing.� It provides faster results, lower cost and less labor for hospital-based laboratories.
Register for EDGAR Pro and access this filing in:     
  FORM 10-Q
    PART I.
      Item 1. Financial Statements
        BALANCE SHEET
        INCOME STATEMENT
        CASH FLOW
        Notes to Financial Statements
      Item 2. Management's Discussion and Analysis of Financial ...
      Item 3. Quantitative and Qualitative Disclosures About ...
      Item 4. Controls and Procedures
    PART II.
      Item 1. Legal Proceedings
      Item 1A. Risk Factors
      Item 6. Exhibits, Financial Statement Schedules
    SIGNATURES
  EXHIBIT 31.1
    CERTIFICATION
  EXHIBIT 31.2
    CERTIFICATION
  EXHIBIT 32.1
    CERTIFICATION PURSUANT TO
  EXHIBIT 32.2
    CERTIFICATION PURSUANT TO
BROKERAGE PARTNERS